Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 9/2020

25.05.2020 | Retinal Disorders

Removal of foveal hard exudates by subretinal balanced salt solution injection using 38-gauge needle in diabetic patients

verfasst von: Kazuyuki Kumagai, Nobuchika Ogino, Marie Fukami, Mariko Furukawa

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To examine the anatomic and visual outcomes after removal of foveal hard exudates through a macular hole created by subretinal balanced salt solution (BSS) injection.

Methods

This was a retrospective, consecutive, case series. Six patients (7 eyes) underwent vitrectomy with removal of foveal hard exudates. All patients were women and the mean age was 65 years (range from 55 to 71). All patients had a history of panretinal photocoagulation. Previous treatments included intravitreal anti-vascular endothelial growth factor injection in one eye and vitrectomy in both eyes of one patient. The geometric mean preoperative decimal visual acuity was 0.11 (range from 0.08 to 0.3). The mean postoperative follow-up period was 12 months (range from 6 to 19). The status of lens was two phakic and five pseudophakic. Surgical procedures included simultaneous cataract surgery if phakic, creation of posterior vitreous detachment if not present, internal limiting membrane (ILM) peeling and a gas or air tamponade. Manual subretinal BSS injection using 38-gauge needle was performed at ILM-peeled area. Removal of foveal hard exudates was conducted by the water flow through the macular hole created during subretinal BSS injection.

Results

Foveal hard exudates decreased in all cases early after surgery. The geometric mean final decimal visual acuity was 0.31 (range from 0.1 to 0.9). Visual acuity improved more than 0.2 LogMAR units in six eyes and unchanged in one eye. There was no severe complication and recurrence of macular edema.

Conclusion

This procedure may be effective for foveal hard exudates in diabetic patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Klein BE, Moss SE, Klein R, Surawicz TS (1991) The Wisconsin epidemiologic study of diabetic retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 98:1261–1265CrossRef Klein BE, Moss SE, Klein R, Surawicz TS (1991) The Wisconsin epidemiologic study of diabetic retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 98:1261–1265CrossRef
2.
Zurück zum Zitat Chew EY, Klein ML, Ferris FL 3rd, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ, Miller D (1996) Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol 114:1079–1084CrossRef Chew EY, Klein ML, Ferris FL 3rd, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ, Miller D (1996) Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol 114:1079–1084CrossRef
3.
Zurück zum Zitat Fong DS, Segal PP, Myers F, Ferris FL, Hubbard LD, Davis MD (1997) Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol 115:873–877CrossRef Fong DS, Segal PP, Myers F, Ferris FL, Hubbard LD, Davis MD (1997) Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol 115:873–877CrossRef
4.
Zurück zum Zitat Møller F, Bek T (2003) The relation between visual acuity, fixation stability, and the size and location of foveal hard exudates after photocoagulation for diabetic maculopathy: a 1-year follow-up study. Graefes Arch Clin Exp Ophthalmol 241:458–462CrossRef Møller F, Bek T (2003) The relation between visual acuity, fixation stability, and the size and location of foveal hard exudates after photocoagulation for diabetic maculopathy: a 1-year follow-up study. Graefes Arch Clin Exp Ophthalmol 241:458–462CrossRef
5.
Zurück zum Zitat Nakamura Y, Tatsumi T, Arai M, Takatsuna Y, Mitamura Y, Yamamoto S (2009) Subthreshold micropulse diode laser photocoagulation for diabetic macular edema with hard exudates. Nippon Ganka Gakkai Zasshi 113:787–791 Article in JapanesePubMed Nakamura Y, Tatsumi T, Arai M, Takatsuna Y, Mitamura Y, Yamamoto S (2009) Subthreshold micropulse diode laser photocoagulation for diabetic macular edema with hard exudates. Nippon Ganka Gakkai Zasshi 113:787–791 Article in JapanesePubMed
7.
Zurück zum Zitat Gordon B, Chang S, Kavanagh M, Berrocal M, Yannuzzi L, Robertson C, Drexler A (1991) The effects of lipid lowering on diabetic retinopathy. Am J Ophthalmol 112:385–391CrossRef Gordon B, Chang S, Kavanagh M, Berrocal M, Yannuzzi L, Robertson C, Drexler A (1991) The effects of lipid lowering on diabetic retinopathy. Am J Ophthalmol 112:385–391CrossRef
8.
Zurück zum Zitat Gupta A, Gupta V, Thapar S, Bhansali A (2004) Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol 137:675–682PubMed Gupta A, Gupta V, Thapar S, Bhansali A (2004) Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol 137:675–682PubMed
9.
Zurück zum Zitat Kawasaki R, Konta T, Nishida K (2018) Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: a real-world observational analysis of a health claims database. Diabetes Obes Metab 20:2351–2360CrossRef Kawasaki R, Konta T, Nishida K (2018) Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: a real-world observational analysis of a health claims database. Diabetes Obes Metab 20:2351–2360CrossRef
11.
Zurück zum Zitat Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S (2004) Intravitreal triamcinolone for the treatment of refractory diabetic macular edema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 88:1131–1136CrossRef Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S (2004) Intravitreal triamcinolone for the treatment of refractory diabetic macular edema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 88:1131–1136CrossRef
12.
Zurück zum Zitat Khairallah M, Zeghidi H, Ladjimi A, Yahia SB, Attia S, Zaouali S, Messaoud R (2005) Primary intravitreal triamcinolone acetonide for diabetic massive macular hard exudates. Retina 25:835–839CrossRef Khairallah M, Zeghidi H, Ladjimi A, Yahia SB, Attia S, Zaouali S, Messaoud R (2005) Primary intravitreal triamcinolone acetonide for diabetic massive macular hard exudates. Retina 25:835–839CrossRef
13.
Zurück zum Zitat Avci R, Kaderli B (2006) Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates. Graefes Arch Clin Exp Ophthalmol 244:28–35CrossRef Avci R, Kaderli B (2006) Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates. Graefes Arch Clin Exp Ophthalmol 244:28–35CrossRef
14.
Zurück zum Zitat Cekiç O, Bardak Y, Tiğ US, Yildizoğlu U, Bardak H (2008) Quantitative evaluation of reduction of plaque-like hard exudates in diabetic macular edema after intravitreal triamcinolone injection. Int Ophthalmol 28:95–99CrossRef Cekiç O, Bardak Y, Tiğ US, Yildizoğlu U, Bardak H (2008) Quantitative evaluation of reduction of plaque-like hard exudates in diabetic macular edema after intravitreal triamcinolone injection. Int Ophthalmol 28:95–99CrossRef
16.
Zurück zum Zitat Pemp B, Deák G, Prager S, Mitsch C, Lammer J, Schmidinger G, Scholda C, Schmidt-Erfurth U, Bolz M, Diabetic Retinopathy Research Group Vienna (2014) Distribution of intraretinal exudates in diabetic macular edema during anti-vascular endothelial growth factor therapy observed by spectral domain optical coherence tomography and fundus photography. Retina 34:2407–2415. https://doi.org/10.1097/IAE.0000000000000250CrossRefPubMed Pemp B, Deák G, Prager S, Mitsch C, Lammer J, Schmidinger G, Scholda C, Schmidt-Erfurth U, Bolz M, Diabetic Retinopathy Research Group Vienna (2014) Distribution of intraretinal exudates in diabetic macular edema during anti-vascular endothelial growth factor therapy observed by spectral domain optical coherence tomography and fundus photography. Retina 34:2407–2415. https://​doi.​org/​10.​1097/​IAE.​0000000000000250​CrossRefPubMed
19.
Zurück zum Zitat Thomas MA, Grand MG, Williams DF, Lee CM, Pesin SR, Lowe MA (1992) Surgical management of subfoveal choroidal neovascularization. Ophthalmology 99:952–968 discussion 975-976CrossRef Thomas MA, Grand MG, Williams DF, Lee CM, Pesin SR, Lowe MA (1992) Surgical management of subfoveal choroidal neovascularization. Ophthalmology 99:952–968 discussion 975-976CrossRef
20.
Zurück zum Zitat Takagi H, Otani A, Kiryu J, Ogura Y (1999) New surgical approach for removing massive foveal hard exudates in diabetic macular edema. Ophthalmology 106:249–256 discussion 256-257CrossRef Takagi H, Otani A, Kiryu J, Ogura Y (1999) New surgical approach for removing massive foveal hard exudates in diabetic macular edema. Ophthalmology 106:249–256 discussion 256-257CrossRef
21.
Zurück zum Zitat Sakuraba T, Suzuki Y, Mizutani H, Nakazawa M (2000) Visual improvement after removal of submacular exudates in patients with diabetic maculopathy. Ophthalmic Surg Lasers 31:287–291PubMed Sakuraba T, Suzuki Y, Mizutani H, Nakazawa M (2000) Visual improvement after removal of submacular exudates in patients with diabetic maculopathy. Ophthalmic Surg Lasers 31:287–291PubMed
22.
Zurück zum Zitat Kumagai K, Ogino N, Furukawa M, Demizu S, Atsumi K, Kurihara H, Iwaki M, Ishigooka H, Tachi N (2002) Surgical removal of subfoveal hard exudates in diabetic maculopathy]. [Article in Japanese. Nippon Ganka Gakkai Zasshi 106:595–601PubMed Kumagai K, Ogino N, Furukawa M, Demizu S, Atsumi K, Kurihara H, Iwaki M, Ishigooka H, Tachi N (2002) Surgical removal of subfoveal hard exudates in diabetic maculopathy]. [Article in Japanese. Nippon Ganka Gakkai Zasshi 106:595–601PubMed
23.
Zurück zum Zitat Furukawa M, Kumagai K, Ogino N, Demizu S, Ishigooka H, Tachi N (2003) Subretinal washout for subtle subfoveal hard exudates in diabetic macular edema. Nippon Ganka Gakkai Zasshi 107:369–374 Article in JapanesePubMed Furukawa M, Kumagai K, Ogino N, Demizu S, Ishigooka H, Tachi N (2003) Subretinal washout for subtle subfoveal hard exudates in diabetic macular edema. Nippon Ganka Gakkai Zasshi 107:369–374 Article in JapanesePubMed
24.
Zurück zum Zitat Takaya K, Suzuki Y, Mizutani H, Sakuraba T, Nakazawa M (2004) Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy. Retina 24:23–29CrossRef Takaya K, Suzuki Y, Mizutani H, Sakuraba T, Nakazawa M (2004) Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy. Retina 24:23–29CrossRef
25.
Zurück zum Zitat Avci R, Inan UU, Kaderli B (2008) Long-term results of excision of plaque-like foveal hard exudates in patients with chronic diabetic macular oedema. Eye (Lond) 22:1099–1104CrossRef Avci R, Inan UU, Kaderli B (2008) Long-term results of excision of plaque-like foveal hard exudates in patients with chronic diabetic macular oedema. Eye (Lond) 22:1099–1104CrossRef
26.
Zurück zum Zitat Naito T, Matsushita S, Sato H, Katome T, Nagasawa T, Shiota H (2008) Results of submacular surgery to remove diabetic submacular hard exudates. J Med Investig 55:211–215CrossRef Naito T, Matsushita S, Sato H, Katome T, Nagasawa T, Shiota H (2008) Results of submacular surgery to remove diabetic submacular hard exudates. J Med Investig 55:211–215CrossRef
29.
Zurück zum Zitat Yang CM (2000) Surgical treatment for severe diabetic macular edema with massive hard exudates. Retina 20:121–125CrossRef Yang CM (2000) Surgical treatment for severe diabetic macular edema with massive hard exudates. Retina 20:121–125CrossRef
Metadaten
Titel
Removal of foveal hard exudates by subretinal balanced salt solution injection using 38-gauge needle in diabetic patients
verfasst von
Kazuyuki Kumagai
Nobuchika Ogino
Marie Fukami
Mariko Furukawa
Publikationsdatum
25.05.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 9/2020
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-020-04756-y

Weitere Artikel der Ausgabe 9/2020

Graefe's Archive for Clinical and Experimental Ophthalmology 9/2020 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Open Access 22.02.2024 | Peeling | Originalien

Selektive Vitalfarbstoffe in der Makulachirurgie

Erhöhen sie die Wahrscheinlichkeit der intraoperativen ILM-Identifizierung auch bei einem erfahrenen Operateur?

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.